Disclaimer: This site aggregates publicly available data from official government sources (FDA, ClinicalTrials.gov, PubMed, SEC EDGAR, NMPA) for general reference only. It does NOT constitute medical advice, diagnosis, treatment recommendations, or investment advice.

Clinical Trial

ClearSight NextGen1 Study

NCT: NCT07317648 · COMPLETED

NCT IDNCT07317648
StatusCOMPLETED
Start Date2025-10-16
Completion2026-03-05

Brief Summary

A prospective, non-randomized single arm study using the investigational ClearSight NextGen (CSNG) system in adult subjects.

Frequently Asked Questions

What is ClearSight NextGen1 Study?

ClearSight NextGen1 Study is a clinical trial registered under NCT07317648. Current status: COMPLETED.

What is the status of NCT07317648?

The current status of NCT07317648 (ClearSight NextGen1 Study) is: COMPLETED.

When did ClearSight NextGen1 Study start?

ClearSight NextGen1 Study started on 2025-10-16.

Official Source

View on ClinicalTrials.gov →

Data sourced from ClinicalTrials.gov API. For the most current status, refer to the official record.

↑